ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPSED OR REFRACTORY AGGRESSIVE NON HODGKIN LYMPHOMA WITH ACTIVE DISEASE

被引：0
|
作者：
Stasia, A. [1 ]
Bozzani, S. [1 ]
Parma, M. [2 ]
Pioltelli, P. [2 ]
机构：
[1] Univ Milano Bicocca, Osped San Gerardo Monza, Milan, Italy
[2] Osped San Gerardo, Monza, Italy
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B1720
引用
收藏
页码：671 / 671
页数：1
相关论文
共 50 条
  • [31] Allogeneic Stem Cell Transplantation in Refractory/Relapsed Lymphoma Patients
    Kapoor, Jyotsna
    Agrawal, Narendra
    Mehta, Pallavi
    Ahmed, Rayaz
    Bhurani, Dinesh
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S252 - S253
  • [32] Brentuximab Vedotin Strategies for Relapsed Or Refractory Hodgkin's Lymphoma And Hematopoietic Stem Cell Transplantation
    Garzon-Velasquez, Katheryn
    Lizeth Acosta-Maldonado, Brenda
    Manuel Valero-Saldana, Luis
    Moreira-Ponce, Carolina
    Marcela Aguado-Vazquez, Tania
    Maylen Rivera-Fong, Liliana
    Rivas-Vera, Silvia
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 252 - 253
  • [33] Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma: A Retrospective single-center Analysis of 23 Patients
    Kata, Dariusz
    Wieczorkiewicz-Kabut, Agata
    Helbig, Grzegorz
    Kopera, Malgorzata
    Zimnoch, Aleksandra
    Witosz, Kamil
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 526 - 527
  • [34] Brentuximab vedotin for relapse or progression therapy after allogeneic hematopoietic stem cell transplantation in relapsed / refractory classic Hodgkin lymphoma
    Mikhailova, N.
    Popova, M.
    Kondakova, E.
    Ivanova, M.
    Borzenkova, E.
    Alaynskiy, A.
    Bondarenko, S.
    Afanasyev, B.
    Babenko, E.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S503 - S503
  • [35] Allogeneic Stem Cell Transplantation for Patients with Relapsed Chemorefractory Aggressive Non-Hodgkin Lymphomas
    Hamadani, Mehdi
    Benson, Don M., Jr.
    Hofmeister, Craig C.
    Elder, Patrick
    Blum, William
    Porcu, Pierluigi
    Garzon, Ramiro
    Blum, Kristie A.
    Lin, Thomas S.
    Marcucci, Guido
    Devine, Steven M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (05) : 547 - 553
  • [36] Reduced-intensity conditioning allogeneic stem cell transplantation for patients with refractory or relapsed non-Hodgkin lymphoma
    De Lavallade, H.
    Bouabdallah, R.
    Faucher, C.
    Furst, S.
    El Cheikh, J.
    Vey, N.
    Stoppa, A. M.
    Sainty, D.
    Arnoulet, C.
    Xerri, L.
    Cassier, P.
    Gastaut, J. A.
    Blaise, D.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S149 - S149
  • [37] Involved field radiation therapy and donor lymphocyte infusion for relapsed or refractory non-Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation
    Behre, G.
    Christopeit, M.
    Weber, T.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (04) : 463 - 464
  • [38] Involved field radiation therapy and donor lymphocyte infusion for relapsed or refractory non-Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation
    G. Behre
    M. Christopeit
    T. Weber
    International Journal of Hematology, 2008, 88 : 463 - 464
  • [39] Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma
    Dann, EJ
    Daugherty, CK
    Larson, RA
    BONE MARROW TRANSPLANTATION, 1997, 20 (05) : 369 - 374
  • [40] Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin’s disease and non-Hodgkin’s lymphoma
    EJ Dann
    CK Daugherty
    RA Larson
    Bone Marrow Transplantation, 1997, 20 : 369 - 374
12345